Contact this trialFirst, we need to learn more about you.
CDK9 inhibitor
TP-1287 for Advanced Cancer
Recruiting1 awardPhase 1
Greenville, South Carolina
This trial tests TP-1287, an oral medicine that blocks a protein needed by cancer cells to grow. It targets patients with advanced cancers who do not respond to standard treatments. The goal is to find the best dose and see if it helps control the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.